Surfactants modify the release from tablets made of hydrophobically modified poly (acrylic acid)

Results in Pharma Sciences

Volumn 3, Issue 1, 2013, Pages 7-14

  Knöös, Patrik ^a   Onder, Sebla ^a   Pedersen, Lina ^a   Piculell, Lennart ^a   Ulvenlund, Stefan ^a,b   Wahlgren, Marie ^a  

^a LUND UNIVERSITY   (Sweden)

^b CR Competence AB   (Sweden)

Author keywords

Controlled release tablets; Cross linked polymers; Dissolution; Hydrophobically modified polymers; Surfactant polymer interactions

Indexed keywords

BILE SALT; CARBOMER; DODECYL SULFATE SODIUM; IBUPROFEN; PEMULEN; POLYACRYLIC ACID; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; CRITICAL MICELLE CONCENTRATION; DRUG SOLUBILITY; EROSION; FLOW KINETICS; GEL; HYDROPHOBICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET MATRIX;

EID: 84884932412     PISSN: None     EISSN: 22112863     Source Type: Journal    
DOI: 10.1016/j.rinphs.2013.08.001     Document Type: Article

References (60)

1. Stegemann S, Leveiller F, Franchi D, de Jong H, Linden H When poor solubility becomes an issue: from early stage to proof of concept. European Journal of Pharmaceutical Sciences 2007, 31:249-261.
2. Leuner C, Dressman J Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50:47-60.
3. Serajuddin ATM Solid dispersion of poorly water-soluble drug: early promises, subsequent problems, and recent breakthroughs. Journal of Pharmaceutical Sciences 1999, 88:1058-1066.
4. Tajarobi F, Abrahmsen-Alami S, Larsson A Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets. Journal of Pharmaceutical Sciences 2011, 100:275-283.
5. Cooper ER Nanoparticles:a personal experience for formulating poorly water soluble drugs. Journal of Controlled Release 2010, 141:300-302.
6. Horter D, Dressman JB Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Advanced Drug Delivery Reviews 2001, 46:75-87.
7. Sigfridsson K, Lundqvist AJ, Strimfors M Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development. Drug Development and Industrial Pharmacy 2009, 35:1479-1486.
8. Hancock BC, Zografi G Characteristics and significance of the amorphous state in pharmaceutical systems. Journal of Pharmaceutical Sciences 1997, 86:1-12.
9. Balakrishnan A, Rege BD, Amidon GL, Polli JE Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. Journal of Pharmaceutical Sciences 2004, 93:2064-2075.
10. Loftsson T, Brewster ME Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. Journal of Pharmaceutical Sciences 1996, 85:1017-1025.
11. Kleberg K, Jacobsen J, Mullertz A Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. Journal of Pharmacy and Pharmacology 2010, 62:1656-1668.
12. Mithani SD, Bakatselou V, TenHoor CN, Dressman JB Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharmaceutical Research 1996, 13:163-167.
13. Mou DS, Chen HB, Wan JL, Xu HB, Yang XL Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. International Journal of Pharmaceutics 2011, 413:237-244.
14. Woo JS, Song YK, Hong JY, Lim SJ, Kim CK Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. European Journal of Pharmaceutical Sciences 2008, 33:159-165.
15. Lee KWY, Porter CJH, Boyd BJ The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug. Journal of Pharmaceutical Sciences 2013, 102:565-578.
16. Nguyen TH, Tan A, Santos L, Ngo D, Edwards GA, Porter CJH, Prestidge CA, Boyd BJ Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: an in vivo evaluation. Journal of Controlled Release 2013, 167:85-91.
17. Porter CJH, Trevaskis NL, Charman WN Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nature Reviews Drug Discovery 2007, 6:231-248.
18. Ahuja A, Khar RK, Chaudhry R Evaluation of buccoadhesive metronidazole tablets: microbiological response. Pharmazie 1998, 53:264-267.
19. Ali J, Khar RK, Ahuja A Formulation and characterisation of a buccoadhesive erodible tablet for the treatment of oral lesions. Pharmazie 1998, 53:329-334.
20. Ceschel GC, Maffei P, Borgia SL, Ronchi C Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Delivery 2001, 8:161-171.
21. Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. European Journal of Pharmaceutics and Biopharmaceutics 2001, 52:45-55.
22. Guo JH Investigating the surface-properties and bioadhesion of buccal patches. Journal of Pharmacy and Pharmacology 1994, 46:647-650.
23. Li C, Bhatt PP, Johnston TP Transmucosal delivery of oxytocin to rabbits using a mucoadhesive buccal patch. Pharmaceutical Development and Technology 1997, 2:265-274.
24. Pedrazzi V, Lara EHG, Panzeri H, Collett JH, Issa JPM In vitro fluoride release and tensile bond strength of a polymeric intra-buccal bioadhesive. International Journal of Morphology 2009, 27:801-803.
25. Shin SC, Kim JY Enhanced permeation of triamcinolone acetonide through the buccal mucosa. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50:217-220.
26. Callens C, Adriaens E, Dierckens K, Remon JP Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. Journal of Controlled Release 2001, 76:81-91.
27. Callens C, Remon JP Evaluation of starch-maltodextrin-Carbopol 974 P mixtures for the nasal delivery of insulin in rabbits. Journal of Controlled Release 2000, 66:215-220.
28. El-Shafy MA, Kellaway IW, Taylor G, Dickinson PA Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits. Journal of Drug Targeting 2000, 7:355-361.
29. Ugwoke MI, Agu RU, Jorissen M, Augustijns P, Sciot R, Verbeke N., Kinget R Nasal toxicological investigations of Carbopol 971P formulation of apomorphine: effects on ciliary beat frequency of human nasal primary cell culture and in vivo on rabbit nasal mucosa. European Journal of Pharmaceutical Sciences 2000, 9:387-396.
30. Witschi C, Mrsny RJ In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery. Pharmaceutical Research 1999, 16:382-390.
31. Ceulemans J, Vermeire A, Adriaens E, Remon JP, Ludwig A Evaluation of a mucoadhesive tablet for ocular use. Journal of Controlled Release 2001, 77:333-344.
32. Davies NM, Farr SJ, Hadgraft J, Kellaway IW Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. Pharmaceutical Research 1992, 9:1137-1144.
33. Durrani AM, Farr SJ, Kellaway IW Precorneal clearance of mucoadhesive microspheres from the rabbit eye. Journal of Pharmacy and Pharmacology 1995, 47:581-584.
34. Dash AK, Gong Z, Miller DW, Huai-Yan H, Laforet J Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. International Journal of Pharmaceutics 1999, 190:21-34.
35. SAMR Aboofazeli, Mortazavi SA An investigation into the effect of carbopols on the release of propranolol HCl from tablet matrices. Iranian Journal of Pharmaceutical Research 2003, 2:23-27.
36. Betageri GV, Deshmukh DV, Gupta RB Oral sustained-release bioadhesive tablet formulation of didanosine. Drug Development and Industrial Pharmacy 2001, 27:129-136.
37. Khan GM, Jiabi Z Formulation and in vitro evaluation of ibuprofen-carbopol (R) 974P-NF controlled release matrix tablets III: influence of co-excipients on release rate of the drug. Journal of Controlled Release 1998, 54:185-190.
38. Khan GM, Zhu JB Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. Journal of Controlled Release 1999, 57:197-203.
39. Simovic S, Tamburic S, Milic-Askrabic J, Rajic D An investigation into interactions between polyacrylic polymers and a non-ionic surfactant: an emulsion preformulation study. International Journal of Pharmaceutics 1999, 184:207-217.
40. Wahlgren M, Christensen KL, Jorgensen EV, Svensson A, Ulvenlund S Oral-based controlled release formulations using poly(acrylic acid) microgels. Drug Development and Industrial Pharmacy 2009, 35:922-929.
41. Aboofazeli SAMR, Mortazavi SA An investigation intothe optimization of release profile of lithium carbonate from matrix-type tablets containing Carbopols, Pemulen and Eudragits. Iranian Journal of Pharmaceutical Research 2003, 8:2-33.
42. Paulsson M, Edsman K Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers. Journal of Colloid and Interface Science 2002, 248:194-200.
43. Paulsson M, Edsman K Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants. Pharmaceutical Research 2001, 18:1586-1592.
44. Paulsson M, Edsman K Controlled drug release from gels using surfactant aggregates: I. Effect of lipophilic interactions for a series of uncharged substances. Journal ofPharmaceutical Sciences 2001, 90:1216-1225.
45. Colombo P Swelling-controlled release in hydrogel matrices for oral route. Advanced Drug Delivery Reviews 1993, 11:37-57.
46. Colombo P, Bettini R, Santi P, Peppas NA Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. PharmaceuticalScience and Technology Today 2000, 3:198-204.
47. Borgquist P, Korner A, Piculell L, Larsson A, Axelsson A A model for the drug release from a polymer matrix tablet-effects of swelling and dissolution. Journal of Controlled Release 2006, 113:216-225.
48. Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA Drug polymer matrix swelling and dissolution. Pharmaceutical Research 1988, 5:488-494.
49. Siepmann J, Podual K, Sriwongjanya M, Peppas NA, Bodmeier R A new model describing the swelling and drug release kinetics from hydroxypropyl methylcellulose tablets. Journal of Pharmaceutical Sciences 1999, 88:65-72.
50. Kaunisto E, Marucci M, Borgquist P, Axelsson A Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems. International Journal of Pharmacy 2011, 418:54-77.
51. Korner A, Larsson A, Piculell L, Wittgren B Molecular information on the dissolution of polydisperse polymers: mixtures of long and short poly(ethylene oxide). Journal of Physical Chemistry B 2005, 109:11530-11537.
52. Dualeh AJ, Steiner CA Hydrophobic microphase formation in surfactant solutions containing an amphiphilic graft copolymer. Macromolecules 1990, 23:251-255.
53. Magny B, Iliopoulos I, Audebert R, Piculell L, Lindman B Interactions between hydrophobically modified polymers and surfactants. Progressin Colloid and Polymer Science 1992, 89:118-121.
54. Piculell I, Thuresson K, Lindman B Mixed solutions of surfactant and hydrophobically modified polymer. Polymers for Advanced Technologies 2001, 12:44-69.
55. Holmberg BJK, Kronberg B, Lindman B Surfactants and polymers in aqueous solutions 2003, John Wiley & Sons Ltd., Chichester. 2nd ed.
56. Patist A, Bhagwat SS, Penfield KW, Aikens P, Shah DO On the measurement of critical micelle concentrations of pure and technical-grade nonionic surfactants. Journal ofSurfactants and Detergents 2000, 3:53-58.
57. Suradkar YR, Bhagwat SS CMC determination of an odd carbon chain surfactant (C13E20) mixed with other surfactants using a spectrophotometric technique. Journal of Chemical and Engineering Data 2006, 51:2026-2031.
58. Marques EF, Edlund H, La Mesa C, Khan A Liquid crystals and phase equilibria binary bile salt-water systems. Langmuir 2000, 16:5178-5186.
59. Mazer NA, Carey MC, Kwasnick RF, Benedek GB Quasi-elastic light-scattering studies of aqueous biliary lipid systems-size, shape, and thermodynamics of bile-salt micelles. Biochemistry 1979, 18:3064-3075.
60. Dressman JB, Amidon GL, Reppas C, Shah VP Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharmaceutical Research 1998, 15:11-22.